Join the Alzheimer’s Association and Charter Research for a special education program about the 10 warning signs of Alzheimer’s.
Join our family of readers for as little as $5 per month and support local, unbiased journalism.
Already have an account? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |
Alzheimer’s and other dementias cause memory, thinking and behavior problems that interfere with daily living. Join the Alzheimer’s Association and Charter Research for a special education program about the 10 warning signs of Alzheimer’s. The event will take place virtually at 1 p.m. ET/noon CT on Wednesday, Dec. 1.
Learn how to recognize common signs of Alzheimer’s disease, how to approach someone about memory concerns, the importance of early detection, the benefits of a diagnosis, possible tests and assessments for the diagnostic process, and Alzheimer’s Association resources. In addition, Jeffrey Norton, M.D., will present on the importance of participating in clinical trials.
Norton is a principal investigator at Charter Research, where he leads clinical research studies of investigational medications for Alzheimer’s disease. Norton’s research work includes clinical trials of BAN2401, an investigational treatment for Alzheimer’s disease that has shown positive results in early research in reducing amyloid plaques and raising scores on standardized memory tests.
Prior to joining Charter Research, Norton spent 20 years in anesthesiology and pain management at Massachusetts General Hospital, New England Neurological Associates and Northeast Rehabilitation Hospital. He graduated from the Hahnemann University School of Medicine and completed his residency in anesthesiology and his fellowship in pain management at Massachusetts General Hospital in Boston, Massachusetts.
Norton is also currently conducting research on a new medication that has been approved for the treatment of Alzheimer’s disease in China and is under evaluation for FDA approval in the United States.
This free educational event is open to anyone interested in learning about Alzheimer’s and dementia and clinical trial participation. To register, visit http://bit.ly/3kn57aD or call 800.272.3900.
About the Alzheimer’s Association
The Alzheimer’s Association leads the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. For more information, visit alz.org or call the 24/7 Helpline at 800.272.3900.
